Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2022 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Mar 26, 2022
Slide 1: Supplementary Slides Q1 2022
SUPPLEMENTARY SLIDES Q1 2022 For the period ended March 26, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q1 2022 (In CAD millions unless otherwise noted) Q1 2022 Q1 2021 % Change (1) Consolidated Revenue $12,262 $11,872 ↑ +3.3% Adjusted EBITDA $1,343 $1,218 ↑ +10.3% Adjusted EBITDA Margin 11.0% 10.3% ↑ +70 bps Adjusted Net Earnings Avaliable to Common Shareholders $
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q1 2022 (In CAD millions unless otherwise noted) Q1 2022 Q1 2021 % Change (1) Total Retail Revenue $12,045 $11,670 ↑ 3.2% Retail Revenue - Food $8,682 $8,479 ↑ 2.4% Retail Revenue - Drug $3,363 $3,191 ↑ 5.4% Pharmacy $1,724 $1,614 ↑ 6.8% Front Store $1,639 $1,5
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q1 2022 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ 2.1% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↓ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +5.2%